Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
ESC 24 in Review with Dr Purvi Parwani
Added: 1 year ago
In this episode of Parallax, Dr Ankur Kalra reunites with Dr Purvi Parwani for a deep dive into the groundbreaking data unveiled at ESC Congress 2024.Dr Parwani, Director of the Women's Cardiovascular Disease Clinic and a leading expert in her field, serves as Associate Professor of Medicine and Director of the Echocardiography Laboratory for Advanced Cardiovascular Imaging at Loma Linda… View more

Intervention

Demographic
Amin Yehya
Research Area(s) / Expertise: Job title: Lead Physician for the Mechanical Circulatory Support
Dr Amin Yehya isLead Physician for the Mechanical Circulatory Support atSentara Heart in Norfolk, VA. Dr Yehya studied his medical degree at the American University of Beirut, and completed his residency at Emory University School of Medicine. He then completed his cardiovascular diseases fellowship at the Medical College of Georgia, before studying advanced heart failure and transplant at… View more
Beta-Blockers Show No Benefit Post-MI in Normal LVEF
Added: 5 months ago Source:  Radcliffe Cardiology
A large-scale meta-analysis of individual patient data has found that beta-blocker therapy does not reduce the risk of major adverse cardiovascular events in patients with a preserved left ventricular ejection fraction (LVEF) following a myocardial infarction (MI).¹ The findings, from the Beta-Blocker Trialists’ Collaboration Study Group, question the routine use of this drug class in this… View more

MI/ACS

Prevention & Chronic Conditions
Addressing the Challenges in Cardiorenal Patient Care
Author(s): Clara Saldarriaga Added: 10 months ago
Catch up on this dynamic symposium from Heart Failure 2025, now available on demand, as Dr Kieran Docherty (University of Glasgow, Glasgow, UK), Prof Clara Saldarriaga (CardioVID Clinic, Medellin, CO) and Prof Gianluigi Savarese (Karolinska Institute, Stockholm, SE) dive into the complexities of treating patients with both heart failure and chronic kidney disease. Through expert conversation and… View more

Cardiovascular Renal Metabolic

Heart Failure
Transcatheter Solutions for the Treatment of Mitral and Tricuspid Disease
Author(s): Robert Cubeddu, MD , Dee Dee Wang , Viviana Navas, MD Added: 1 year ago
Learn from your interventional, imaging and heart failure colleagues about the latest in recognizing and treating patients with mitral and tricuspid valve disease. Explore case-based discussions, brush up on the latest clinical data and guidelines and learn more about new approved technologies for your valvular disease patients. View more

Intervention

Guidelines & Statements
Ep 144: ESC 25 in Review with Dr Purvi Parwani
Added: 6 months ago
In this evidence-packed episode of Parallax, Dr Ankur Kalra welcomes back Dr Purvi Parwani, Associate Professor of Medicine at Loma Linda University Health, for a comprehensive review of groundbreaking trials presented at the European Society of Cardiology Congress.Dr Parwani guides listeners through what she describes as a "tectonic shift" in post-MI care with the REBOOT and BETAMI-DANBLOCK… View more

Guidelines & Statements

Heart Failure
AHA 24: The ENDEAVOR Trial
Author(s): Added: 1 year ago
AHA Conference 2024 - Primary safety and efficacy results from ENDEAVOR investigating the effect of myeloperoxidase inhibition with mitiperstat (AstraZeneca) on symptoms and exercise capacity in patients with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF).Dr Sanjiv Shah (Bluhm Cardiovascular Institute, Chicago, US) joins us onsite at AHA Conference to discuss the… View more

Heart Failure
HRS 25: The BIO-LIBRA Study
Author(s): Valentina Kutyifa Added: 11 months ago
HRS 2025 - Contemporary outcomes from implantable devices in non-ischemic cardiomyopathy patients observed more advanced heart failure symptoms in women at the time of ICD implantation, and white women implanted with CRT-D devices had significantly lower ventricular arrhythmia events compared to men of all races and black women implanted with both device types.Dr Valentina Kutyifa (University of… View more

Demographic

Electrophysiology & Arrhythmia
3 Trials That Will Change My Practice with Dr Deepak Bhatt
Author(s): Deepak L Bhatt Added: 2 weeks ago
ACC 2026 — Dr Deepak Bhatt (Mount Sinai Fuster Heart Hospital, US) delivers his expert verdict on three late-breaking clinical trials from ACC 2026 that are poised to influence cardiovascular care and future clinical guidelines.Dr Bhatt highlights data updates from the SURPASS-CVOT trial, exploring expanded cardiometabolic findings with tirzepatide versus dulaglutide, discusses the HI-PEITHO… View more

Intervention

Anticoagulation
Beta-Blockers Cut MACE Risk Post-MI in Normal EF Patients
Added: 4 months ago Source:  Radcliffe Cardiology
The role of long-term beta-blocker therapy following a myocardial infarction (MI) in patients without heart failure remains a subject of clinical debate, particularly in the modern era of reperfusion and secondary prevention. The BETAMI–DANBLOCK trial sought to address this evidence gap by evaluating the efficacy of beta-blockers in this specific patient population.¹BETAMI–DANBLOCK was an open… View more

MI/ACS

Prevention & Chronic Conditions